biotech · Lupus Nephritis - WHO Class III · Non Hodgkin Lymphoma · ARTV
Artiva Biotherapeutics
Artiva Biotherapeutics patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
San Diego, USA HQ
2019 Founded
105 Employees
Public company Type
ARTV · NYSE Ticker
Company details
- Status
- Public
- HQ
- San Diego, USA
- Founded
- 2019
- Employees
- 105
- Programs
- 8
- Drugs
- 9
- Patents
- 0
Artiva Biotherapeutics patents
0 pharmaceutical patents indexed for Artiva Biotherapeutics. 0 expire within 24 months.
Artiva Biotherapeutics has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Artiva Biotherapeutics have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Artiva Biotherapeutics patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.